https://drugnews.com.tw/articles/2026-10-13-galleri-positive-signal-diagnostic-journey.html Drugnews｜藥時事 zh-tw 2026-10-13T00:05:00.000Z 滴血驗癌真的來了？ https://drugnews.com.tw/articles/2026-10-13-galleri-positive-signal-diagnostic-journey-en.html Drugnews｜藥時事 en 2026-10-13T00:00:00.000Z Has Cancer Detection from a Blood Sample Really Arrived? https://drugnews.com.tw/articles/2026-10-13-argenx-sjogrens-unity-futility-mechanism.html Drugnews｜藥時事 zh-tw 2026-10-13T00:00:00.000Z 乾燥症三期喊停，argenx 押錯的是機制不是藥 https://drugnews.com.tw/articles/2026-10-12-keytruda-qlex-subcutaneous-delivery-value-en.html Drugnews｜藥時事 en 2026-10-12T00:00:00.000Z Defending its blockbuster, Merck hits a patent wall https://drugnews.com.tw/articles/2026-10-12-keytruda-qlex-subcutaneous-delivery-value.html Drugnews｜藥時事 zh-tw 2026-10-12T00:00:00.000Z 藥王保衛戰，默沙東撞上專利牆 https://drugnews.com.tw/articles/2026-10-11-pediatric-obesity-novo-wegovy-lilly-product-strategy.html Drugnews｜藥時事 zh-tw 2026-10-11T07:19:01.000Z 兒少肥胖用藥：Novo 的先發優勢，為何還要靠 Wegovy 接棒？